Anorexigenic effects of miglitol in concert with the alterations of gut hormone secretion and gastric emptying in healthy subjects

Hormone and Metabolic Research

Volumn 44, Issue 4, 2012, Pages 312-318

  Kaku, H ^a   Tajiri, Y ^a   Yamada, K ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

glucosidase inhibitor; appetite; ghrelin; glucagon like peptide 1; peptide YY; visual analogue scales

Indexed keywords

GASTROINTESTINAL HORMONE; GHRELIN; MIGLITOL; RECOMBINANT GLUCAGON;

ADULT; APPETITE; ARTICLE; CARBON DIOXIDE BREATHING; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; MALE; MEAL; NORMAL HUMAN; PRIORITY JOURNAL; SATIETY; STOMACH EMPTYING; VISUAL ANALOG SCALE;

1-DEOXYNOJIRIMYCIN; ADULT; APPETITE; APPETITE DEPRESSANTS; FEMALE; GASTRIC EMPTYING; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HUMANS; MALE; OBESITY; PEPTIDE YY; YOUNG ADULT;

EID: 84859431580     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1304563     Document Type: Article

References (36)

1. Ranganath L, Norris F, Morgan L, Wright J, Marks V. Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect. Diabet Med: 1998; 15 120 124 (Pubitemid 28096276)
2. Goke B, Fuder H, Wieckhorst G, Theiss U, Stridde E, Littke T, Kleist P, Arnold R, Lucker P W. Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve. Digestion: 1995; 56 493 501
3. Herrmann C, Goke R, Richter G, Fehmann H C, Arnold R, Goke B. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion: 1995; 56 117 126
4. Hameed S, Dhillo W S, Bloom S R. Gut hormones and appetite control. Oral Dis: 2009; 15 18 26
5. Naslund E, Gutniak M, Skogar S, Rossner S, Hellstrom PM. Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr: 1998; 68 525 530 (Pubitemid 28402372)
6. Turton M D, O'Shea D, Gunn I, Beak S A, Edwards C M, Meeran K, Choi S J, Taylor G M, Heath M M, Lambert P D, Wilding J P, Smith D M, Ghatei M A, Herbert J, Bloom S R. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature: 1996; 379 69 72 (Pubitemid 26008136)
7. Lee A, Patrick P, Wishart J, Horowitz M, Morley J E. The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics. Diabetes Obes Metab: 2002; 4 329 335 (Pubitemid 34947095)
8. Adrian T E, Ferri G L, Bacarese-Hamilton A J, Fuessl H S, Polak J M, Bloom S R. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology: 1985; 89 1070 1077 (Pubitemid 16231572)
9. Grandt D, Schimiczek M, Beglinger C, Layer P, Goebell H, Eysselein V E, Reeve J R Jr. Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept: 1994; 51 151 159
10. Batterham R L, Cowley M A, Small C J, Herzog H, Cohen M A, Dakin C L, Wren A M, Brynes A E, Low M J, Ghatei M A, Cone R D, Bloom S R. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature: 2002; 418 650 654
11. Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal M S, Suganuma T, Matsukura S, Kangawa K, Nakazato M. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology: 2000; 141 4255 4261
12. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature: 1999; 402 656 660 (Pubitemid 129516334)
13. Cummings D E, Purnell J Q, Frayo R S, Schmidova K, Wisse B E, Weigle D S. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes: 2001; 50 1714 1719 (Pubitemid 33641587)
14. Inui A, Asakawa A, Bowers C Y, Mantovani G, Laviano A, Meguid M M, Fujimiya M. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J: 2004; 18 439 456 (Pubitemid 38326301)
15. Alberti K G, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med: 2006; 23 469 480
16. Harano Y, Miyawaki T, Nabiki J, Shibachi M, Adachi T, Ikeda M, Ueda F, Nakano T. Development of cookie test for the simultaneous determination of glucose intolerance, hyperinsulinemia, insulin resistance and postprandial dyslipidemia. Endocr J: 2006; 53 173 180
17. Ghoos Y F, Maes B D, Geypens B J, Mys G, Hiele M I, Rutgeerts P J, Vantrappen G. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology: 1993; 104 1640 1647 (Pubitemid 23235453)
18. Perri F, Bellini M, Portincasa P, Parodi A, Bonazzi P, Marzio L, Galeazzi F, Usai P, Citrino A, Usai-Satta P. (13)C-octanoic acid breath test (OBT) with a new test meal (EXPIROGer): Toward standardization for testing gastric emptying of solids. Dig Liver Dis: 2010; 42 549 553
19. Stubbs R J, Hughes D A, Johnstone A M, Rowley E, Reid C, Elia M, Stratton R, Delargy H, King N, Blundell J E. The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings. Br J Nutr: 2000; 84 405 415
20. Moser E B. Repeated measures modeling with PROC mixed, In SUGI 29. In: Owen D. (ed.). Repeated measures modeling with PROC mixed. Montreal.: 2004; 188-29 1 19
21. Fukase N, Takahashi H, Manaka H, Igarashi M, Yamatani K, Daimon M, Sugiyama K, Tominaga M, Sasaki H. Differences in glucagon-like peptide-1 and GIP responses following sucrose ingestion. Diabetes Res Clin Pract: 1992; 15 187 195
22. Qualmann C, Nauck M A, Holst J J, Orskov C, Creutzfeldt W. Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose). Scand J Gastroenterol: 1995; 30 892 896
23. Seifarth C, Bergmann J, Holst J J, Ritzel R, Schmiegel W, Nauck M A. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients. Diabet Med: 1998; 15 485 491
24. Hucking K, Kostic Z, Pox C, Ritzel R, Holst J J, Schmiegel W, Nauck M A. alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients. Diabet Med: 2005; 22 470 476 (Pubitemid 40516249)
25. DeLeon M J, Chandurkar V, Albert S G, Mooradian A D. Glucagon-like peptide-1 response to acarbose in elderly type 2 diabetic subjects. Diabetes Res Clin Pract: 2002; 56 101 106 (Pubitemid 34226625)
26. Toft-Nielsen M B, Damholt M B, Madsbad S, Hilsted L M, Hughes T E, Michelsen B K, Holst J J. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab: 2001; 86 3717 3723 (Pubitemid 32755966)
27. Requejo F, Uttenthal L O, Bloom S R. Effects of alpha-glucosidase inhibition and viscous fibre on diabetic control and postprandial gut hormone responses. Diabet Med: 1990; 7 515 520 (Pubitemid 20199797)
28. Karczewska-Kupczewska M, Straczkowski M, Adamska A, Nikolajuk A, Otziomek E, Gorska M, Kowalska I. Increased suppression of serum ghrelin concentration by hyperinsulinemia in women with anorexia nervosa. Eur J Endocrinol: 2010; 162 235 239
29. Saad M F, Bernaba B, Hwu C M, Jinagouda S, Fahmi S, Kogosov E, Boyadjian R. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab: 2002; 87 3997 4000 (Pubitemid 34879561)
30. Kirchner H, Tong J, Tschop M H, Pfluger P T. Ghrelin and PYY in the regulation of energy balance and metabolism: lessons from mouse mutants. Am J Physiol Endocrinol Metab: 2010; 298 E909 E919
31. Witte A B, Gryback P, Holst J J, Hilsted L, Hellstrom P M, Jacobsson H, Schmidt P T. Differential effect of PYY1-36 and PYY3-36 on gastric emptying in man. Regul Pept: 2009; 158 57 62
32. Anini Y, Hansotia T, Brubaker P L. Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats. Endocrinology: 2002; 143 2420 2426 (Pubitemid 34521588)
33. Jang H J, Kokrashvili Z, Theodorakis M J, Carlson O D, Kim B J, Zhou J, Kim H H, Xu X, Chan S L, Juhaszova M, Bernier M, Mosinger B, Margolskee R F, Egan J M. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci USA: 2007; 104 15069 15074 (Pubitemid 47619594)
34. Lee S, Yabe D, Nohtomi K, Takada M, Morita R, Seino Y, Hirano T. Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes. Endocr J: 2010; 57 119 126
35. Kirchner H, Gutierrez J A, Solenberg P J, Pfluger P T, Czyzyk T A, Willency J A, Schurmann A, Joost H G, Jandacek R J, Hale J E, Heiman M L, Tschop M H. GOAT links dietary lipids with the endocrine control of energy balance. Nat Med: 2009; 15 741 745
36. Julious S A. Sample sizes for clinical trials with normal data. Stat Med: 2004; 23 1921 1986